These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 3198171)

  • 1. A sensitive ELISA for detection of circulating antigens in kala azar patients.
    Sinha R; Arora SK; Sehgal S
    Indian J Med Res; 1988 Aug; 88():138-40. PubMed ID: 3198171
    [No Abstract]   [Full Text] [Related]  

  • 2. Detection of leishmania antigen in kala azar patients using monoclonal antibodies.
    Sinha R; Arora SK; Datta U; Sehgal S
    Microbiol Immunol; 1992; 36(4):391-400. PubMed ID: 1406366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ELISA titres to polysaccharide antigens of Leishmania donovani promastigotes in kala-azar.
    Ray R; Ghose AC
    Trans R Soc Trop Med Hyg; 1986; 80(6):998. PubMed ID: 3603654
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunodiagnosis of kala-azar.
    Srivastava L
    J Commun Dis; 1985; 17(1 Suppl):83-8. PubMed ID: 3913701
    [No Abstract]   [Full Text] [Related]  

  • 5. Identification of new antigens in visceral leishmaniasis by expression cloning and immunoblotting with sera of kala-azar patients from Bihar, India.
    Theinert SM; Basu R; Forgber M; Roy S; Sundar S; Walden P
    Infect Immun; 2005 Oct; 73(10):7018-21. PubMed ID: 16177384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges in the diagnosis of post kala-azar dermal leishmaniasis.
    Salotra P; Singh R
    Indian J Med Res; 2006 Mar; 123(3):295-310. PubMed ID: 16778312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sero-epidemiological study of kala-azar in a village of Varanasi district, India.
    Kumar R; Pai K; Kumar P; Pandey HP; Sundar S
    Trop Med Int Health; 2006 Jan; 11(1):41-8. PubMed ID: 16398754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunodiagnosis of Kala-azar by ELISA using intact promastigote.
    Mittal V; Sehgal S; Singh VK
    J Commun Dis; 1988 Dec; 20(4):321-6. PubMed ID: 3268597
    [No Abstract]   [Full Text] [Related]  

  • 9. Diagnosis of kala-azar--an important stride.
    Sundar S
    J Assoc Physicians India; 2003 Aug; 51():753-5. PubMed ID: 14651132
    [No Abstract]   [Full Text] [Related]  

  • 10. Bulk production and comparison of promastigote and amastigote antigens of Leishmania donovani for serodiagnosis and value of serum protein and immunoglobulin changes in diagnosis of kala-azar cases.
    Dutta GD; Dutta GP
    J Commun Dis; 1985; 17(1 Suppl):77-82. PubMed ID: 3831071
    [No Abstract]   [Full Text] [Related]  

  • 11. Kala-azar infected serum circulating antigens and their characteristics detected by monoclonal antibody.
    Hu XS; Liu Q; Lin FQ; Yi TL; Wang YJ; Qin Z; Luo P; Wang L
    Chin Med J (Engl); 1988 Jan; 101(1):1-6. PubMed ID: 3142725
    [No Abstract]   [Full Text] [Related]  

  • 12. Lipophosphoglycan masks recognition of the Leishmania donovani promastigote surface by human kala-azar serum.
    Karp CL; Turco SJ; Sacks DL
    J Immunol; 1991 Jul; 147(2):680-4. PubMed ID: 2071901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a rapid immunochromatographic test for diagnosis of kala-azar & post kala-azar dermal leishmaniasis at a tertiary care centre of north India.
    Mathur P; Samantaray J; Chauhan NK
    Indian J Med Res; 2005 Dec; 122(6):485-90. PubMed ID: 16517998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of enzyme-linked immunosorbent assay in the diagnosis of kala-azar in Malda district (West Bengal).
    Gupta S; Srivastava JK; Ray S; Chandra R; Srivastava VK; Katiyar JC
    Indian J Med Res; 1993 Nov; 97():242-6. PubMed ID: 8144206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive management of Indian visceral leishmaniasis: clinical application of diagnosis by K39 antigen strip testing at a kala-azar referral unit.
    Sundar S; Sahu M; Mehta H; Gupta A; Kohli U; Rai M; Berman JD; Murray HW
    Clin Infect Dis; 2002 Sep; 35(5):581-6. PubMed ID: 12173133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of amastigote-specific antigens of Leishmania donovani using kala-azar patient sera.
    Gupta N; Goyal N; Bhatia N; Kamboj KK; Rastogi AK
    Indian J Exp Biol; 2001 Jul; 39(7):623-8. PubMed ID: 12019753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of ELISA & indirect immunofluorescence in sero-epidemiology of kala-azar.
    Srivastava L; Chakravarty AK; Kumar A; Kumar P
    Indian J Med Res; 1984 Jun; 79():744-8. PubMed ID: 6394475
    [No Abstract]   [Full Text] [Related]  

  • 18. Diagnosis of visceral leishmaniasis: comparative potential of amastigote antigen, recombinant antigen and PCR.
    Sreenivas G; Ansari NA; Singh R; Subba Raju BV; Bhatheja R; Negi NS; Salotra R
    Br J Biomed Sci; 2002; 59(4):218-22. PubMed ID: 12572956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The leishmanin test and immunity in kala azar.
    MANSON-BAHR PE
    East Afr Med J; 1961 Apr; 38():165-7. PubMed ID: 13766296
    [No Abstract]   [Full Text] [Related]  

  • 20. Micro-enzyme-linked-immunosorbent assay in diagnosis of kala-azar.
    Xu ZB; Xiong J; You JY; Zhong HL; Chen WK; Zhao EM; Jiao LE; Li JS
    Chin Med J (Engl); 1982 Sep; 95(9):649-52. PubMed ID: 6817988
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.